The numbers were supposed to settle the argument. They haven’t.
Palantir’s second-quarter earnings report, released to a market still nursing wounds from a brutal first half, triggered the kind of rally that makes traders check their terminals twice. The stock climbed 31.17 percent over seven trading sessions — with the immediate post-earnings jump landing at 29.11 percent to close at 141.12 euros — as investors scrambled to reposition around a growth profile that even the company’s own management struggled to articulate with conventional language. CEO Alex Karp called the quarter “out-of-this-world,” a phrase that sits uneasily alongside the sober tone executives typically reserve for earnings calls.
The Numbers That Forced a Repricing
The headline figures were difficult to dismiss. Revenue for the second quarter reached 1.94 billion US dollars, up 93 percent year over year and well ahead of the 1.81 billion analysts had penciled in. Adjusted earnings per share of 0.41 US dollars — matching GAAP results — blew past the consensus estimate of 0.34 US dollars. The US commercial business, the engine room of Palantir’s growth narrative, expanded 149 percent to 764 million US dollars, while the government segment added 90 percent growth to reach 809 million. Combined, US revenue climbed 115 percent to 1.57 billion US dollars.
Management responded by lifting the full-year outlook with unusual conviction. The company now guides to 8.16 billion US dollars in annual revenue, up from a prior range of 7.65 to 7.66 billion, and has raised its 2026 US commercial target to over 3.42 billion US dollars from 3.22 billion. Operating margin hit 47 percent on a GAAP basis, and adjusted free cash flow reached 1.22 billion US dollars.
The deal pipeline tells a similar story of acceleration. Palantir closed 220 contracts worth at least one million US dollars, including 73 exceeding ten million. Total contract value rose 49 percent to 3.37 billion US dollars, and the remaining deal value in the US commercial segment more than doubled to 6.24 billion US dollars. For bulls, this is the transition from pilot projects to production-scale deployment — the moment when AI software stops being a promise and becomes a procurement line item.
The Chart Tells a Different Story
Yet the price action around this earnings release reveals how far the stock had fallen before this week’s reprieve. Prior to the report, shares were trading at 122.78 US dollars — roughly 40 percent below the all-time high of 207.52 US dollars reached in November 2025. Even after the surge, Palantir remains down 10.27 percent for the year (the secondary data puts the year-to-date decline at 10.18 percent), and the 12-month picture shows a 5.75 percent loss. The current level of 140.98 euros sits about 21 percent below the 52-week high of 179.98 euros.
This is not a breakout into new territory. It is a violent rebound from a deep correction — a distinction that matters for how investors should interpret the move. The market is forgiving Palantir its earlier valuation concerns, but the forgiveness is not yet complete.
Should investors sell immediately? Or is it worth buying Palantir?
Technical indicators suggest the recovery may need to pause before it can continue. The 14-day relative strength index has climbed to 71.8, signaling overbought conditions, while the annualized 30-day volatility of 96.28 percent underscores how fragile sentiment remains. The stock now trades 24.01 percent above its 50-day moving average and 8.60 percent above the 200-day average — stretched positioning that historically invites profit-taking. A minimal daily loss of 0.10 percent in the wake of the rally could be an early sign that the post-earnings euphoria is beginning to cool.
The Bull and Bear Case, Side by Side
Optimists point to the durability of the growth acceleration. The doubling of the US commercial backlog suggests the demand is structural rather than episodic, and the raised guidance implies management sees visibility extending beyond a single quarter. Palantir’s positioning around “AI sovereignty” — the desire of governments and corporations to maintain control over their own data and model weights — has turned the company into a default choice for institutions wary of relying on offshore AI infrastructure. The average analyst price target of 158.07 euros implies roughly 12.1 percent upside from current levels, a modest but respectable return for a stock that has already moved sharply.
Skeptics counter with valuation math that leaves little room for error. Even after the year-to-date decline, the stock prices in near-flawless execution. The government segment’s 90 percent growth rate carries its own risks: public contracts attract political scrutiny, and renewals are never guaranteed. Should prominent government deals draw negative attention in coming quarters, sentiment could shift quickly. The annualized volatility figure of 98.41 percent in the secondary data — slightly higher than the primary source’s 96.28 percent — illustrates just how violently the stock can swing in either direction.
There is also the uncomfortable precedent of strong quarters failing to produce sustained rallies. Palantir’s shares have demonstrated before that impressive fundamentals do not automatically translate into a permanently higher stock price. The stock currently sits 51.25 percent above its 52-week low of 93.30 US dollars from June, a cushion that keeps bears at bay — but also a reminder of how far the stock can fall when expectations reset.
The November Test
The immediate question is whether the US commercial growth rate of 149 percent can hold, or whether it settles into a lower but more sustainable trajectory. That debate will not be resolved by the current rally. The next concrete checkpoint arrives in November, when third-quarter results are due. By then, investors will see whether the raised commercial guidance of over 3.42 billion US dollars represents genuine momentum or an optimistic stretch.
For now, the verdict is split. The fundamental story has genuinely shifted: Palantir is executing ahead of the software industry, and the raised guidance reflects a structural acceleration rather than a one-off beat. But the chart needs room to breathe. With the RSI in overbought territory and volatility running at extreme levels, the stock’s path back to its November high of 179.98 euros — a remaining climb of roughly 21 percent — is unlikely to be a straight line. Patience, rather than chase buying, may be the more prudent approach until the technical picture cools.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from August 5 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 5.
Palantir: Buy or sell? Read more here...
